---
figid: PMC3312932__nihms357065f2
figtitle: Regulation of the human catalytic subunit of telomerase (hTERT)
organisms:
- NA
pmcid: PMC3312932
filename: nihms357065f2.jpg
figlink: /pmc/articles/PMC3312932/figure/F2/
number: F2
caption: The principal protein-protein interactions that regulate hTERT involve cross-regulation
  between hTERT and the cell cycle, carried out largely by cyclin/cdk complexes and
  transcription factors that bind to the hTERT promoter. The cyclic nature of the
  cell cycle is reflected in the dual role of E2F-1 as both repressor and activator.
  Major regulatory pathways exert either repressive, as in the case of the TGF-b pathway,
  or activating influence on both the cell cycle and hTERT expression. The PI3K/Akt,
  NF-kB and MAP kinase pathways all activate. In addition, estrogen (E2) bound to
  estrogen receptor ERa blocks the repressive activity of the TGF-b pathway, as does
  cyclin/cdk phosphorylation of p107. In a positive feedback loop, expression of hTERT
  activates the PI3K/Akt pathway, which activates the cell cycle by MAD1 and p53 degradation,
  activates the NF-kB pathway and potentially blocks the TGF-b pathway. Arrow shapeMeaningDeltaIncrease,
  transcribe, synergy or assembleDiamondActivateTDecrease or blockBallDegrade
papertitle: Regulation of the human catalytic subunit of telomerase (hTERT).
reftext: Michael Daniel, et al. Gene. ;498(2):135-146.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8376721
figid_alias: PMC3312932__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3312932__F2
ndex: ad090b81-df20-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3312932__nihms357065f2.html
  '@type': Dataset
  description: The principal protein-protein interactions that regulate hTERT involve
    cross-regulation between hTERT and the cell cycle, carried out largely by cyclin/cdk
    complexes and transcription factors that bind to the hTERT promoter. The cyclic
    nature of the cell cycle is reflected in the dual role of E2F-1 as both repressor
    and activator. Major regulatory pathways exert either repressive, as in the case
    of the TGF-b pathway, or activating influence on both the cell cycle and hTERT
    expression. The PI3K/Akt, NF-kB and MAP kinase pathways all activate. In addition,
    estrogen (E2) bound to estrogen receptor ERa blocks the repressive activity of
    the TGF-b pathway, as does cyclin/cdk phosphorylation of p107. In a positive feedback
    loop, expression of hTERT activates the PI3K/Akt pathway, which activates the
    cell cycle by MAD1 and p53 degradation, activates the NF-kB pathway and potentially
    blocks the TGF-b pathway. Arrow shapeMeaningDeltaIncrease, transcribe, synergy
    or assembleDiamondActivateTDecrease or blockBallDegrade
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - dpp
  - gbb
  - put
  - mav
  - CycA
  - Cdk4
  - rb
  - DCTN6-p27
  - dap
  - CG9588
  - CycE
  - AP-1gamma
  - Jra
  - kay
  - CycD
  - Zdhhc8
  - Arpc5
  - Su(osk)P16
  - era
  - Sp1
  - grass
  - Spn42Dd
  - E2f1
  - Med
  - ras
  - Ras64B
  - Ras85D
  - Myc
  - Mnt
  - Lamtor2
  - MKP-4
  - p38b
  - rl
  - p53
  - betaTub60D
  - hth
  - S6kII
  - CSN5
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CTCF
  - caz
  - Taf9
  - Taf8
  - Taf10b
  - Taf10
  - Taf12L
  - Taf11
  - nht
  - Taf13
  - Tbp
  - Taf2
  - Taf4
  - Taf6
  - mia
  - Taf1
  - Taf7
  - Taf12
  - Spt3
  - Taf3
  - Taf5
  - Akt
  - S6k
  - Dif
  - dl
  - Rel
  - NFAT
  - IKKepsilon
  - key
  - IKKbeta
  - Mtor
  - Tor
  - E2F4
  - TGFB1
  - TGFB2
  - TGFB3
  - RBL1
  - SMAD3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - INHBC
  - CDKN2A
  - H3P10
  - ESR1
  - ERAL1
  - SP1
  - PSG1
  - DAND5
  - E2F1
  - UBE2L3
  - CDC25A
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - SMAD4
  - NFKBIA
  - MXD3
  - KRAS
  - HRAS
  - NRAS
  - TERT
  - IGF2
  - MYC
  - MNT
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TP53
  - TP63
  - TP73
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - COPS5
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MDM2
  - TBP
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MTOR
  - Cancer
  - Lung cancer
---
